Literature DB >> 21999891

Treatment of complex cervical dystonia with botulinum toxin: involvement of deep-cervical muscles may contribute to suboptimal responses.

Roongroj Bhidayasiri1.   

Abstract

Complex cervical dystonia is a subgroup of cervical dystonia (CD) characterised by a combination of head deviations in more than one plane. In addition to superficial neck muscles, deep-cervical muscles contribute to a broad range of neck movements. These deep muscles include prevertebral muscles for primary neck flexion, lateral vertebral muscles for shoulder elevation and head tilt and a posterior group of muscles for neck extension. The authors describe three cases of complex deviations of the neck including anterocollis, retrocollis and lateral or sagittal shifts with involvement of deep-cervical muscles, which are not easily accessible by routine botulinum toxin (BoNT) therapy. Incomplete muscle selection may be one of the causes of treatment failures with BoNT in patients with complex CD, and targeting of deep-cervical muscles should be considered when patients exhibit complex deviations involving anterocollis, retrocollis, lateral or sagittal shifts.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21999891     DOI: 10.1016/j.parkreldis.2011.06.015

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  9 in total

Review 1.  Treatment of dystonia.

Authors:  Mary Ann Thenganatt; Joseph Jankovic
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 2.  Diagnosis and treatment of dystonia.

Authors:  H A Jinnah; Stewart A Factor
Journal:  Neurol Clin       Date:  2015-02       Impact factor: 3.806

3.  Clinimetric testing of the comprehensive cervical dystonia rating scale.

Authors:  Cynthia L Comella; Joel S Perlmutter; Hyder A Jinnah; Tracy A Waliczek; Ami R Rosen; Wendy R Galpern; Charles A Adler; Richard L Barbano; Stewart A Factor; Christopher G Goetz; Joseph Jankovic; Stephen G Reich; Ramon L Rodriguez; William L Severt; Mateusz Zurowski; Susan H Fox; Glenn T Stebbins
Journal:  Mov Disord       Date:  2016-03-12       Impact factor: 10.338

Review 4.  Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation.

Authors:  Ian O Bledsoe; Aaron C Viser; Marta San Luciano
Journal:  Neurotherapeutics       Date:  2020-10-23       Impact factor: 7.620

Review 5.  The focal dystonias: current views and challenges for future research.

Authors:  H A Jinnah; Alfredo Berardelli; Cynthia Comella; Giovanni Defazio; Mahlon R Delong; Stewart Factor; Wendy R Galpern; Mark Hallett; Christy L Ludlow; Joel S Perlmutter; Ami R Rosen
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

6.  Botulinum toxin treatment failures in cervical dystonia: causes, management, and outcomes.

Authors:  H A Jinnah; Emily Goodmann; Ami R Rosen; Marian Evatt; Alan Freeman; Stewart Factor
Journal:  J Neurol       Date:  2016-04-25       Impact factor: 4.849

Review 7.  Relevance of sonography for botulinum toxin treatment of cervical dystonia: an expert statement.

Authors:  Axel Schramm; Tobias Bäumer; Urban Fietzek; Susanne Heitmann; Uwe Walter; Wolfgang H Jost
Journal:  J Neural Transm (Vienna)       Date:  2014-12-30       Impact factor: 3.575

8.  Long-term quality of life in cervical dystonia after treatment with abobotulinum toxin A: a 2-year prospective study.

Authors:  Subsai Kongsaengdao; Narong Maneeton; Benchalak Maneeton
Journal:  Neuropsychiatr Dis Treat       Date:  2018-04-26       Impact factor: 2.570

Review 9.  A methodological approach for botulinum neurotoxin injections to the longus colli muscle in dystonic anterocollis: A case series of 4 patients and a literature review.

Authors:  Yury Seliverstov; Sergey Arestov; Sergey Klyushnikov; Yuliya Shpilyukova; Sergey Illarioshkin
Journal:  J Clin Neurosci       Date:  2020-08-26       Impact factor: 1.961

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.